News

Prescription drug commercials anger some, please others

Pharmaceutical companies are spending close to $10 billion per year on direct-to-consumer advertising in the U.S. Only the entertainment industry spends more. Is that a good thing?

FDA clears next-gen hybrid system for intravascular imaging

Conavi Medical's new hybrid imaging system simultaneously performs IVUS and OCT.

US doctors still bouncing back from COVID-era burnout

Physician burnout rates continue to fall, and the healthy trend comes alongside strong and stable rates of physician job satisfaction.

Heart Rhythm 2025 Heart Rhythm Society President Kenneth A. Ellenbogen, MD

Heart Rhythm 2026 to feature late-breaking EP data, hands-on training and more

Heart Rhythm 2026 in Chicago will include a total of 18 late-breaking clinical trials—and that is just the beginning. The four-day event kicks off April 23.

Gregg Stone, MD, FACC, FSCAI, Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai Hospital in New York, presented the results of the long-awaited STEMI Door or Unloading time trial, which takes a different approach to first using a percutaneous heart pump to unload the heart 30 minutes prior to PCI interventions to try and prevent common complications and improve outcomes.

Late-breaking PCI data challenge the 'time is muscle' paradigm

Gregg Stone, MD, spoke to Cardiovascular Business about the lessons he and his colleagues learned from the STEMI DTU trial.

Weight loss pill linked to reduced risk of heart attack or stroke after FDA requested more data

The FDA asked, and Eli Lilly and Company delivered. The company now hopes to secure an additional approval for orforglipron/Foundayo that covers the treatment of type 2 diabetes.

Where physicians have become more litigious than hospitals over unpaid patient bills

Of all lawsuits filed against patients in 2024 in one U.S. state, physician practices and other non-hospital healthcare entities accounted for 80% of cases. That’s a complete inversion from just six years prior.

AI scribes add at least $167 per month to clinician income: 5-site study

In the three or so years since it burst into healthcare, ambient AI scribe technology has run away with the win in the market-uptake race. What has been the return on investment in all those software packages?

U.S. Department of Health and Human Services (HHS) sign.

Leaked HHS budget reveals 30% cuts, elimination of many core services

A proposal for the massive restructuring of the Department of Health and Human Services ends funding to programs associated with chronic disease management, lead safety, and Head Start. However, HHS is adding a new department to focus on understanding the cause of long-term illness.

Pre-procedure patient questionnaires reduce IR scheduling hiccups

Increased demand for interventional procedures has inevitably resulted in more patients with complex medical needs entering the IR suite.

Cardiology, radiology professionals unite to explore the challenges of diagnosing CAD in women

Coronary artery disease is both underdiagnosed and undertreated in women, and they often receive less guideline-recommended care than men. Why do these disparities persist? And what can today’s healthcare providers do to bring about change?

Solo Pace Incorporated SoloPace Control System

Cardiologist-founded startup announces FDA clearance, first uses of new TAVR pacing system

“The device takes variability out of the procedure by giving the operator full control while automating ramp-up and back-up algorithms," according to a clinician who used the new technology. "The TAVR procedure is simplified, reducing physician and staff workload."

Around the web

Health Exec

Prescription drug commercials anger some, please others

Pharmaceutical companies are spending close to $10 billion per year on direct-to-consumer advertising in the U.S. Only the entertainment industry spends more. Is that a good thing?